Enovis Corp Deferred Tax Assets, in Process Research and Development
Enovis Corp (ENOV) had Deferred Tax Assets, in Process Research and Development of $16.70 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, in Process Research and Development $16.70M.
- 2024-12-31: Deferred Tax Assets, in Process Research and Development $13.30M.
- 2023-12-31: Deferred Tax Assets, in Process Research and Development $10.50M.
- 2022-12-31: Deferred Tax Assets, in Process Research and Development $9.30M.
| Period end | Deferred Tax Assets, in Process Research and Development |
|---|---|
| 2025-12-31 | $16.70M 10-K · filed 2026-02-26 |
| 2024-12-31 | $13.30M 10-K · filed 2025-02-26 |
| 2023-12-31 | $10.50M 10-K · filed 2024-02-22 |
| 2022-12-31 | $9.30M 10-K · filed 2023-03-01 |
| 2021-12-31 | $16.60M 10-K · filed 2022-02-22 |
| 2020-12-31 | $14.00M 10-K · filed 2021-02-18 |
| 2019-12-31 | $9.90M 10-K · filed 2020-02-24 |
| 2018-12-31 | $1.40M 10-K · filed 2019-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |